Table 1 Trends in relative survival (%) by sex, time since diagnosis and calendar period of diagnosis: England and Wales, adults (15–99 years) diagnosed during 1986–1999 and followed up to 2001

From: Survival from adult leukaemia in England and Wales up to 2001

  

Calendar period of diagnosis a

    
  

1986–1990

1991–1995

1996–1999

Average change (%) every 5 years b

Prediction c for patients diagnosed during 2000–2001

Time since diagnosis

 

Survival (%)

95% CI

Survival (%)

95% CI

Survival (%)

95% CI

Survival (%)

95% CI

Survival (%)

95% CI

1 year

Men

56.7

(55.6, 57.7)

60.0

(59.1, 60.9)

61.9

(60.9, 62.9)

2.9 **

(1.0, 4.9)

61.3

(59.8, 62.7)

 

Women

52.8

(51.7, 53.9)

55.6

(54.5, 56.6)

57.3

(56.1, 58.4)

1.5

(−0.7, 3.7)

56.2

(54.6, 57.9)

5 years

Men

30.7

(29.6, 31.7)

35.3

(34.3, 36.3)

39.7

(38.4, 41.0)

4.7 **

(2.4, 7.0)

39.4

(37.8, 41.0)

 

Women

30.0

(28.9, 31.1)

34.5

(33.3, 35.6)

35.9

(34.4, 37.3)

1.7

(−0.8, 4.2)

35.4

(33.7, 37.1)

10 years

Men

21.1

(20.1, 22.1)

25.8

(24.6, 27.0)

  

8.4 **

(4.4, 12.5)

29.5

(27.8, 31.2)

 

Women

21.8

(20.7, 22.9)

27.3

(26.0, 28.6)

  

5.2 *

(0.8, 9.7)

28.6

(26.8, 30.4)

  1. CI=confidence interval.
  2. aSurvival estimated with cohort or complete approach (see Rachet et al, 2008).
  3. bMean absolute change (%) in survival every 5 years, adjusted for deprivation (see Rachet et al, 2008).
  4. cSurvival estimated with hybrid approach (see Rachet et al, 2008).
  5. *P<0.05; **P<0.01.